Testing PSMA PET/CT scans for metastatic bladder or skin cancer
Treatments studied
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This Phase 1 study tests how well a PSMA PET/CT scan can find cancer spots in people with metastatic bladder cancer (urothelial cancer) or metastatic melanoma. It may help doctors better see where cancer is and guide next steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older
- You have metastatic bladder cancer or metastatic melanoma confirmed by biopsy (pathology report)
- A doctor has at least one suspicious cancer spot that can be seen on PET/CT (FDG PET/CT and/or CT, depending on the group)
- You can do the scan: you can lie flat, stay still, and tolerate PET scanning
- Your overall health/energy level is not too low (Karnofsky ≥50% or ECOG/WHO 2 or less)
- You agree to sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan called PSMA to see if it can better detect kidney cancer that has spread. It may help find tumors that other scans miss.
This Phase 2 study tests an imaging scan called 18F-PSMA PET/CT to find tumors that have a specific marker (PSMA). It may help doctors better locate and evaluate PSMA-positive cancers.
This study is looking at how well a special type of PET/CT scan (called PSMA PET/CT) can see cancer in people who have or may have certain tumors. It may help doctors better understand and track the disease.
This study looks at how well a special scan (PSMA PET/CT) works for people with cancers other than prostate cancer. If your doctor already scheduled this scan for your care, you may be able to help researchers learn more about its accuracy.
This study uses two different PSMA PET/CT tracers to see how well they detect cancer in patients with advanced prostate cancer that has spread or stopped responding to hormone therapy. The goal is to improve imaging for better treatment decisions.
This trial tests if a special scan (PSMA-PET) can help plan surgery for melanoma that has spread to lymph nodes. It may help doctors remove all cancer more accurately.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.